Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting, has a long half-life allowing for once-daily dosing in treatment-naive patients ...

Palmetto AIDS Life Support Services in Columbia to host event with free testing, referrals and assessments on Thursday ...

Updated recommendations were issued by the IAS-USA regarding the use of ART for treatment and prevention of HIV in adult populations.

On 6 February 2025, the U.S. Department of State’s Bureau of Global Health Security and Diplomacy (GHSD), which oversees global implementation of PEPFAR, issued detailed guidance on activities ...

is urging residents to prioritize early HIV testing to ensure long-term health and curb the spread of the virus. HIV cases surge in Pangasinan HIV compromises the immune system by targeting white ...

MedMira Inc. (MedMira) announced that it has received the approval from Health Canada for its Reveal Rapid G4 HIV-1/2 Test (Reveal HIV test) for Point-of-Care (POC) use. The Reveal HIV rapid test has ...

Investing.com -- Morgan Stanley upgraded Gilead Sciences Inc (NASDAQ:GILD) to "overweight" from "equal weight," raising its price target to $113 from $87 on HIV prevention drug Lenacapavir (PrEP ...

The Satcher Health Leadership Institute at Morehouse School of Medicine in collaboration with Fort Valley State University, ...

The Department of Health (DOH) has dismissed false claims circulating online about supposed "Faculty of Medicine" members visiting households to conduct blood sugar tests using HIV-contaminated ...

Individuals’ fear about knowing their HIV status and testing for it are factors that delay people coming forward, says Lyons. “HIV is just another condition that can be managed and that anyone ...